Evaluate SAGE-547 in Participants With Essential Tremor

NCT02277106 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Tremor

Interventions

DRUG: SAGE-547
DRUG: Placebo

Sponsor

Sage Therapeutics